Invention Grant
- Patent Title: Risk-based control-to-range
-
Application No.: US15170468Application Date: 2016-06-01
-
Publication No.: US10297350B2Publication Date: 2019-05-21
- Inventor: David L. Duke , Christian Ringemann , Chinmay Uday Manohar , Alan Greenburg
- Applicant: Roche Diabetes Care, Inc.
- Applicant Address: US IN Indianapolis
- Assignee: Roche Diabetes Care, Inc.
- Current Assignee: Roche Diabetes Care, Inc.
- Current Assignee Address: US IN Indianapolis
- Agency: Dinsmore & Shohl, LLP
- Main IPC: G01N33/48
- IPC: G01N33/48 ; G16H50/20 ; G16H50/30 ; G06F19/00 ; A61B5/145 ; A61M5/142 ; A61M5/172

Abstract:
Methods and systems are disclosed for determining a basal rate adjustment of insulin based on risk associated with a glucose state of a person with diabetes. A method may include detecting a glucose state of the person based on a received glucose measurement signal and determining a current risk metric associated with the detected glucose state. The method may include determining a current risk metric associated with the detected glucose state based on a weighted average of cumulative hazard values of return paths generated from a glucose state distribution around a detected glucose state. The method may include calculating an adjustment to a basal rate of a therapy delivery device based on the current risk metric associated with the detected glucose state and a reference risk metric associated with a reference glucose level.
Public/Granted literature
- US20170348484A1 RISK-BASED CONTROL-TO-RANGE Public/Granted day:2017-12-07
Information query